World's Leading Website About Dense Breasts

Neoadjuvant chemotherapy (NAT) is commonly used before surgery in women with triple-negative and HER2-positive breast cancers. Multiple studies have established that tamoxifen therapy consistently

NCCN Update: Incorporating 5-Year Risk The March 2026 NCCN breast screening guidelines now include guidance to “consider” supplemental MRI screening for women with a 5-year Gail model risk